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Abstract 
Tryptophan hydroxylase 1 gene (TPH1) encodes a 
rate-limiting enzyme in the biosynthesis of the 
monoamine neurotransmitter serotonin.  
TPH1 is expressed in peripheral tissues such as the 
heart, lung, kidney, duodenum and adrenal gland, as 
well as in female reproductive tissues.  
The mutations in this gene have been associated with 
various diseases with high risk, including, 
schizophrenia, somatic anxiety, anger-related 
features, bipolar disorder, suicidal behavior, and 
several addictions. 
Keywords 
Tryptophan hydroxylase 1, Alzheimer's Disease, 
Serotonin, Intestine, Inflammation, Suicide, 
Schizophrenia, Bipolar disorder 
Identity 
Other names: TRPH, TPH, TPRH 
HGNC (Hugo): TPH1 (tryptophan hydroxylase 1) 
Location 11p15.1 
Local order: shown in Chromosome 11 - 
NC_000011.10 Reference GRCh38.p13 Primary 
Assembly. 
DNA/RNA 
Description 
The gene spans a region of 29 kilobases (kb) and 
consists of 11 exons. 
Transcription 
The gene has 4 transcripts (Table 1). 
Figure 1.  Genomic location of TPH1 gene (Chromosome 11 - NC_000011.10 Reference GRCh38.p13 Primary Assembly)
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Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt 
RefSeq 
Match 
Flags 
TPH1-
201 
ENST00000250018.6 5325 444aa ENSP00000250018.2 
Protein 
coding 
CCDS7829 P17752 - 
TSL:1GENCODE 
basicAPPRIS P1 
TPH1-
204 
ENST00000528338.1 556 165aa ENSP00000436081.1 
Protein 
coding 
- E9PR49 - 
CDS 3' 
incompleteTSL:3 
TPH1-
202 
ENST00000417164.5 1138 206aa ENSP00000403831.1 
Nonsense 
mediated 
decay 
- E7EMX4 - TSL:1 
TPH1-
203 
ENST00000525406.1 461 
No 
protein 
- lncRNA - - - TSL:5 
Table 1. Transcripts of the human TPH1 gene (Ensemble, GRCh38: CM000673.2). 
 
Single nucleotide polymorphisms (SNPs) found in the human TPH1 gene were given in Table 2. 
 
SNP name (Genomic 
localization) 
Position in 
the gene 
SNP ID PCR primers and short-extension probe 
5'flankingSNP1 (T-
1721G) 
5' flanking 
region 
SNP000574351 
F: 5'-ctgttcttttggtgtcctc-3' 
R:5'-gctcctggcacttaacata-3' 
P: 5'-taatttctttcatgagtattttatagtt 
5'flankingSNP2 (A-
1067G) 
5' flanking 
region 
SNP000574353 
F: 5'-ctgttcttttggtgtcctc-3' 
R: 5'-gctcctggcacttaacata-3' 
P: 5'-ttttttgctgagtatggatgtactttaaagctcagga 
5'flankingSNP3 (G-
347T) 
5' flanking 
region 
SNP000574354 
F: 5'-cgataataggcgttatcttg-3' 
R: 5'-ctcaatctctgcgtgtatct-3' 
P: 5'-tcaggactgggctattaaatagcccagaagcacagaga 
in1SNP1 (T3804A) 
Intron 1 
(exon 1c) 
rs623580 
F: 5'-taattatcctccctccaagt-3' R: 5'-
cttacccattcaattaccac-3' 
P: 5'-agagtatgggcgacgttgtccta 
in2SNP1 (G7465A) Intron 2 rs684302 
F: 5'-tgctcttatatgtcttttcaagt-3' 
R: 5'-gagagatggagcaaaacac-3' 
P: 5'-ttaaataaaatacctgtatgtcttcttccatca 
in3SNP1 (A12517C) Intron 3 rs211105 
F: 5'-tcaggaaaacagaagggta-3' 
R: 5'-ggtaaattgccctatttctaa-3' 
P: 5'-aggtggcaaagacaaatgatttctaagatcttttccatcggc 
in6SNP1 (C18626G) Intron 6 rs2237907 
F: 5'-gggaagaaattatgtaagtgg-3' 
R: 5'-gaaatgttccatatctgtgc-3' 
P: 5'-ttgtaatgcacacaaaactgaaagctgatctcttagggtctggagc 
in7SNP1 (A20004C)d Intron 7 rs1800532 
CF: 5'-acccacctacactttcctc-3' CR: 5'-
taattgacaacctattaggttc-3' 
AR: 5'-agcacatgtgaagcatttag-3' 
AF: 5'-cctatgctcagaatagcagctct-3' 
3'UTRSNP1 (C27224T) 3' UTR rs2108977 
F: 5'-cacttgaatatcacagtccatc-3' 
R: 5'-gcttacagtagatttccttgc-3' 
P: 5'-tacatttgatggtaaatagatgctagctaatct 
3'UTRSNP2 
(A27237G) 
3' UTR New 
F: 5'-cacttgaatatcacagtccatc-3' 
R: 5'-gcttacagtagatttccttgc-3' 
P: 5'-aactataaatcagataatcaata 
Table 2. Single nucleotide polymorphisms (SNPs) of the human TPH1 gene (Lai et al. 2005).
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Marker 
Group (Total Number) Genotype (frequency)   Allele (frequency)   
 1-1 1-2 2-2 χ2 p value 1 2 χ2 p value 
T-1721G N(94) 54(.57) 37(.39) 3(.03) 2.72 0.248 145(.77) 43(.23) 0.36 0.548 
 P(92) 53(.58) 31(.34) 8(.09)   137(.75) 47(.26)   
A-1067G N(90) 53(.59) 34(.38) 3(.03) 1.62 0.446 140(.78) 40(.22) 0.74 0.389 
 P(92) 51(.55) 34(.37) 7(.08)   136(.74) 48(.26)   
G-347T N(102) 58(.57) 43(.42) 1(.01) 0.048 0.976 159(.78) 45(.22) 0.037 0.847 
 P(94) 52(.55) 41(.44) 1(.01)   145(.77) 43(.23)   
T3804A N(101) 56(.55) 38(.38) 7(.07) 2.17 0.304 152(.74) 52(.26) 0.015 0.946 
 P(96) 49(.51) 44(.46) 3(.03)   142(.74) 50(.26)   
G7465A N(100) 31(.31) 43(.43) 26(.26) 0.46 0.793 105(.53) 95(.48) 0.439 0.508 
 P(74) 25(.34) 33(.45) 16(.22)   83(.56) 65(.44)   
A12517C N(101) 58(.57) 39(.39) 4(.04) 0.232 0.890 155(.77) 47(.23) 0.207 0.649 
 P(96) 58(.60) 35(.37) 3(.03)   151(.79) 41(.21)   
C18626G N(100) 28(.28) 47(.47) 25(.25) 1.24 0.538 103(.52) 97(.49) 0.392 0.531 
 P(71) 25(.35) 28(.39) 18(.25)   78(.55) 64(.45)   
A20004C N(102) 40(.39) 45(.44) 17(.17) 1.726 0.422 125(.61) 79(.39) 1 795 0.18 
 P(89) 29(.32) 39(.44) 21(.24)   97(.54) 81(.46)   
C27224T N(95) 31(.33) 49(.52) 15(.16) 3.58 0.167 111(.58) 79(.42) 2.13 0.144 
 P(80) 23(.29) 35(.44) 22(.28)   81(.51) 79(.49)   
A27237G N(95) 49(.52) 40(.42) 6(.06) 0.57 0.751 138(.73) 52(.27) 0.677 0.411 
 P(78) 37(.47) 34(.44) 7(.09)   107(.69) 49(.34)   
Table 3. The genotypic and allelic distribution of the TPH1 gene (Lai et al. 2005). 
N indicates the matched normal controls, P indicates the bipolar patients. 1 represents the major allele and 2 the minor allele 
 
The genotypic and allelic distribution of the TPH1 
gene is listed in Table 3. 
Protein 
Description 
Size: 444 amino acids; Molecular mass: 50985 Da; 
Cofactor: Fe (2+); Xref=ChEBI: CHEBI: 29033; 
Quaternary structure: Homotetramer 
Protein properties for TPH1 Gene: TPH1 is a rate-
limiting enzyme in the biosynthesis of serotonin. It 
catalyzes the biotin-dependent monooxygenation of 
tryptophan to 5-hydroxytryptophan (5HTP), then 
decarboxylates to form the neurotransmitter 
serotonin. The gene is localized on the human 
chromosome 11p15.3-p14, is about 29 kb long and 
contains 11 exons (Craig et al. 1991). Jonsson et al. 
(1997) identified single nucleotide polymorphisms 
(SNPs) A218C (rs1800532) and A779C (rs1799913) 
in intron 7 of the TPH1 gene. Mutations in this gene 
have been associated with high risk for various 
diseases and disorders such as schizophrenia, 
somatic anxiety, anger-related features, bipolar 
disorder, suicidal behavior, and several addictions 
(https://www.ncbi.nlm.nih.gov/gene). 
Expression 
TPH1 gene is expressed in peripheral tissues such as 
heart, lung, kidney, duodenum and adrenal gland and 
female reproductive tissues 
(http://www.proteinatlas.org). 
Function 
Remarkably, about 90% of the total serotonin of the 
human body is found in neuroendocrine 
enterochromaffin cells (EC) in the human 
gastrointestinal (GI) tract, where it is used to regulate 
bowel movements (Lukiw and Rogaev, 2017). The 
mouse mammary glands stimulated by prolactin 
(176760) express the genes necessary for serotonin 
biosynthesis, including TPH1 (Matsuda et al. 2004). 
The TPH1 mRNA increased during pregnancy and 
lactation, and serotonin was detected in breast 
epithelium and milk. It has been observed that 
serotonin suppresses beta-casein (115460) 
expression and causes contraction of breast alveoli. 
Accordingly, Matsuda et al. (2004) concluded that 
autocrine-paracrine serotonin signaling is an 
important regulator of breast homeostasis and early 
evolution (Matsuda et al. 2004).  
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Figure 2. The possible mechanisms for microbial regulation of tryptophan and 5HT release (Simplified from Gheorghe et al. 
2019). 
 
The liver is an organ that can regenerate its volume 
after major tissue loss. Lesurtel et al. (2006) showed 
that mouse thrombocytopenia leads to the inhibition 
of cellular proliferation in the liver (Lesurtel et al. 
2006).  
Thrombocytes are the main carriers of serotonin in 
the blood. In thrombocytopenic mice, a serotonin 
agonist has been observed to regenerate liver 
proliferation (Gershon and Tack, 2007). The 
expression of HT2A (182135) and HT2B (601122) 
serotonin receptor subtypes has been observed to 
increase in the liver after hepatectomy. Antagonists 
of these receptors have been shown to inhibit liver 
regeneration.  
Liver regeneration has also been disrupted in mice 
lacking TPH1, the rate-limiting enzyme for the 
synthesis of peripheral serotonin.  Since 
thrombocytes contain most of the circulating 
serotonin, and serotonin is released by thrombocyte 
aggregation, inactivation of TPH1 function is 
assumed to lead to severe blood clotting defects 
(Gershon and Tack, 2007).  
Loss- and gain-of-function mutations in mouse low-
density lipoprotein receptor-related protein 5 ( 
LRP5) gene affected bone formation, leading to 
osteoporosis and increased bone mass, respectively. 
Yadav et al. (2008) described the TPH1 as the most 
over-expressed gene in LRP5 - / - mice and 
concluded that LRP5 suppresses bone formation by 
inhibiting serotonin production (Yadav et al. 2008). 
Enterochromaffin cells (EC) synthesize intestinal 
serotonin (5HT). LRP5 controls 5HT synthesis by 
negatively regulating TPH1 expression in these 
cells. When 5HT is released in the blood, it 
negatively regulates bone formation during bone 
remodeling process (Ducy and Karsenty, 2010).  
Since 5HT is produced in the gut, its effects on the 
intestinal microbiota are inevitable. There is a 
significant difference in the composition of the gut 
microbiota depending on whether the TPH1 is 
knocked out and whether the progenitors are 
heterozygous or homozygous for this gene. Besides, 
there is evidence that 5HT directly modulates the 
growth of commensal bacteria (Kwon et al. 2019). 
The combination of microbial and host 
gastrointestinal metabolism of tryptophan is likely 
an important factor in the systemic availability of 
tryptophan, as well as levels of indoles, kynurenine 
and local 5HT (Roager and Licht, 2018). The 
possible mechanisms for microbial regulation of 
tryptophan and 5HT release are shown in Figure 2 
(Gheorghe et al. 2019). 
Mutations 
Note 
The main mutations in the human TPH1 gene were 
given in Table 4.  
 
Missense/nonsense mutation 
Accessi
on 
HGMD codon change 
HGMD 
amino 
acid 
change 
HGVS 
(nucleotide) 
HGVS 
(protein
) 
Variant class 
Phenotyp
e 
Reference Source 
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CM109
141 
AAA-CAA 
Lys54Gl
n 
c.160A>C p.K54Q 
Disease-
causing 
mutations 
(DM) 
Attention 
deficit 
hyperacti
vity 
disorder 
Halmøy 
(2010) Arch Gen 
Psychiatry 67:1033 
PubMe
d 
20921
119 
CM109
142 
CGT-TGT 
Arg142C
ys 
c.424C>T 
p.R142
C 
Disease-
causing 
mutations 
(DM) 
Attention 
deficit 
hyperacti
vity 
disorder 
Halmøy 
(2010) Arch Gen 
Psychiatry 67:1033 
PubMe
d 
20921
119 
CM109
143 
CGA-TGA 
Arg145T
erm 
c.433C>T p.R145* 
Disease-
causing 
mutations 
(DM) 
Attention 
deficit 
hyperacti
vity 
disorder 
Halmøy 
(2010) Arch Gen 
Psychiatry 67:1033 
PubMe
d 
20921
119 
CM109
149 
GTA-ATA 
Val177Il
e 
c.529G>A p.V177I 
Disease-
causing 
mutations 
(DM) ? 
Attention 
deficit 
hyperacti
vity 
disorder 
Halmøy 
(2010) Arch Gen 
Psychiatry 67:1033 
PubMe
d 
20921
119 
CM109
145 
CTC-ATC 
Leu274Il
e 
c.820C>A p.L274I 
Disease-
causing 
mutations 
(DM) 
Attention 
deficit 
hyperacti
vity 
disorder 
Halmøy 
(2010) Arch Gen 
Psychiatry 67:1033 
PubMe
d 
20921
119 
CM109
146 
GCT-ACT 
Ala300T
hr 
c.898G>A 
p.A300
T 
Disease-
causing 
mutations 
(DM) 
Attention 
deficit 
hyperacti
vity 
disorder 
Halmøy 
(2010) Arch Gen 
Psychiatry 67:1033 
PubMe
d 
20921
119 
CM187
494 
CGT-CAT 
Arg395H
is 
c.1184G>A 
p.R395
H 
Disease-
causing 
mutations 
(DM) ? 
Mood 
dysregula
tion 
disorder 
Ungar (2018) Am J 
Med Genet 
A 176:1432 
PubMe
d 
29696
773 
CM109
144 
ATC-AAC 
Ile410As
n 
c.1229T>A p.I410N 
Disease-
causing 
mutations 
(DM) 
Attention 
deficit 
hyperacti
vity 
disorder 
Halmøy 
(2010) Arch Gen 
Psychiatry 67:1033 
PubMe
d 
20921
119 
Splicing mutation 
Accessi
on 
HGMD codon change 
HGMD 
amino 
acid 
change 
HGVS(nucleoti
de) 
HGVS 
(dbSNP 
number
) 
Variant class 
Phenoty
pe 
Reference 
Sourc
e 
CS0343
23 
IVS6 ds C-A +221 
 not yet 
available 
c.803+221C>A 
rs18005
32 
Disease-
associated 
polymorphisms
  (DP) 
Depressi
on, 
associatio
n with 
Tsai 
(1999) Neuroreport 
10:3773 
PubMe
d 
10716
208 
Regulatory mutation 
Accessi
on 
HGMD codon change 
HGMD 
amino 
acid 
change 
HGVS 
(nucleotide) 
HGVS 
(dbSNP 
number
) 
Variant class 
Phenoty
pe 
Reference 
Sourc
e 
CR1314
899 
GGGCTATTAAATAGCCC
A 
GAAGCACAGAGA(T-
G)GT 
GTGGGAGGTGGGGGGAT
T 
CTTGCTTTGG  
-5854 relative to initiation 
codon 
 not yet 
available 
 not yet available 
rs71309
29 
Disease-
associated 
polymorphisms
  (DP) 
Irritable 
bowel 
syndrome
, 
diarrhoea 
predomin
ant, 
associatio
n with 
Grasberger(2013) A
m J 
Gastroenterol 108:1
766 
PubMe
d 
24060
757 
Small deletion 
Accessi
on 
HGMD codon change 
HGMD 
amino 
HGVS 
HGVS 
(dbSNP 
Variant class 
Phenoty
pe 
Reference 
Sourc
e 
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acid 
change 
number
) 
CD1668
98 
CAGATACATGactTCAGTT
CTTA non-coding region 
 not yet 
available 
c.*1342_*1344d
elACT 
rs60273
374 
Disease-
causing 
mutations 
(DM) ? 
Attention 
deficit 
hyperacti
vity 
disorder, 
persistent 
Demontis (2016) J 
Am Acad Child 
Adolesc 
Psychiatry 55:521 
PubMe
d 
27238
071 
Table 4. Mutations of the human TPH1 gene (http://www.hgmd.cf.ac.uk) 
 
Implicated in 
Breast Cancer 
TPH1 was analyzed in histological samples to learn 
about the possible relationship between changing 
5HT synthesis and human breast cancer progression. 
TPH1 is evenly distributed in the epithelial stroma in 
normal breast tissue and epithelial TPH1 is markedly 
stained. Compared to healthy breast cell lines, TPH1 
staining intensity increased significantly in 
cancerous cell lines (Pai et al. 2009). 
Alzheimer's disease (AD) 
It was observed that the amount of serotonin 
increased 4 times in raphe cell bodies and decreased 
0.4-fold in amygdala synaptic ends in Alzheimer's 
disease (AD) cases compared to controls. As a result 
of the accumulation of oxidative metabolites of 
serotonin and reduced transport of TPH to the axon 
terminals, TPH and its products are accumulated in 
the perikarya of raphe neurons, which may lead to 
the degeneration of serotonergic neurons in AD 
(Lukiw and Rogaev, 2017). In one study, fifty 
percent of patients showed agitation/aggression in 
response to the NPI screening question. A significant 
relationship was observed between 
agitation/aggression in male subjects carrying the C 
allele of the TPH1 gene. A218C polymorphism in 
this gene is linked to aggression and irritability in 
men. Given this, it was concluded that the agitated 
and aggressive behavior in AD is associated with the 
polymorphic variation in the TPH1 gene in men. 
According to these results, TPH (TPH1, chr11p15.1, 
and TPH2, chr12q21.1) gene is considered as one of 
the six genes frequently seen in AD and aggression 
(Lukiw and Rogaev, 2017). 
Suicidal behavior (SB) 
Three polymorphisms of the TPH1 gene, a potential 
GATA transcription factor binding site A218C, 
A779C located in intron 7, and A6526G located in 
the promoter region, were studied in patients with 
suicide attempts (Mirkovic et al. 2016). The A allele 
of A218C was found to be more common in suicide 
attempts than in patients who did not attempt suicide 
(Mirkovic et al. 2016). AA genotypes in the intron 7 
and promoter region were  
 
associated with increased suicide attempts (Galfalvy 
et al. 2009). A relationship between the C allele of 
A218C and suicidal behavior (SB) was found only in 
people over 65 years of age (Stefulj et al. 2006). A 
significant relationship between suicide risk and 
AA218C SNP allele has been reported in Caucasian 
populations (Bellivier et al. 2004). There is a strong 
relationship between SB and A779C / A218C 
polymorphisms in both European and Asian 
populations (Mirkovic et al. 2016).  
The prevalence of TPH1 A218C polymorphism was 
evaluated in a Turkish population and a significant 
relationship was found between the A allele and SB 
(Beden et al. 2016).  
It was shown that not only the AA genotype but also 
the CC genotype was significantly associated with 
suicide risk and depression (Zalsman et al. 2001).  
On the other hand, some studies have reported that 
A218C genotypes are not related to the suicide 
attempt.  
A multi-center case-control study and meta-analysis 
showed that the A218/A779 locus increased 
sensitivity to schizophrenia and contributed to 
psychiatric disorders characterized by high suicide 
rates rather than affecting suicide (Beden et al. 
2016).  
Although it was not associated with SB, there was a 
significant relationship between bipolar disorder 
(BPD) and small alleles of A218C in individuals 
with psychiatric disorders (Beden et al. 2016). 
Schizophrenia 
A study conducted with 837 Scandinavian 
schizophrenic patients and 1473 healthy individuals 
revealed that three of the five SNPs tested are 
associated with schizophrenia sensitivity including 
A218C and A779C polymorphisms (Saetre et 
al. 2010).  
However, it has been shown that there is no 
difference in the allele frequencies of these loci 
among people who have attempted suicide at least 
once and have no history of a suicide attempt (Saetre 
et al. 2010).  
Although TPH1 is expressed mainly in peripheral 
tissues, its variants have been reported to be 
frequently associated with psychiatric disorders. The 
TPH1 gene, shown in Figure 3, is a strong candidate 
gene for schizophrenia (Halmøy et al. 2010). 
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Figure 3.  Representation of TPH1 and other 
Schizophrenia-associated candidate genes (green-colored) 
located on Chromosome 11 
(http://www.szgene.org/chromo.asp?c=11). 
Aggressive Behavior 
The A218C and A779C SNPs (usually called U/top 
and L/bottom alleles) found in the intron of the TPH1 
gene are associated with different aggression 
evaluated by interview and self-reporting 
questionnaires (Rujescu et al. 2002). Lower 
cerebrospinal fluid (CSF) 5-Hydroxyindoleacetic 
acid (5-HIAA) levels were observed in healthy men 
with the U allele (Jonsson et al. 1997), while the 
lowest CSF 5-HIAA levels were observed in LL 
carriers diagnosed with antisocial alcoholism 
(Nielsen et al. 1994). Both U and L alleles were 
thought to be associated with different types of 
aggressiveness (Quadros et al. 2010). Individuals 
with a UU allele have been shown to have more 
aggressive hostility but slightly lower neurotic 
hostility (New et al. 1998). Individuals with a UU 
allele have been shown to have more aggressive 
hostility but slightly lower neurotic hostility (New et 
al. 1998).  
A higher level of impulsivity was found in tests that 
focused on neurotic hostility for LL homozygous 
individuals (Hennig et al. 2005).  
Genetic studies show that the polymorphism in both 
alleles (L and U) of the TPH1 gene is associated with 
human aggression, but each allele is associated with 
a different type of aggression (Quadros et al. 2010). 
Major depressive disorder (MDD) 
The frequency of TPH1 C allele and CC 
homozygous in patients with Major depressive 
disorder (MDD) was higher than healthy individuals 
with the same genotype.  
According to the results of the verbal aggression and 
aggression questionnaire, TPH1 CC homozygotes in 
the MDD group scored significantly higher than the 
A carrier genotypes. It has been revealed that there 
is a relationship between the frequency of this 
polymorphism, aggression, and MDD (Frodl, 2016).  
Vitamin D activates a series of processes that are 
critical for maintaining normal healthy neurons, also 
preventing the onset of depression.  
Where vitamin D enters the nucleus, it joins with the 
retinoid X receptor (RXR) and then binds to the 
vitamin D response element (VDRE) found on a 
large number of genes.  
Eventually, Ca2+ homeostasis is maintained by 
inducing the expression of the calcium-binding 
proteins (calbindin and parvalbumin), SLC8A1 
(Na2+/Ca2+ exchanger1 NCX1) and cell membrane 
Ca2+ ATPase (PMCA) pump (ATP2B1 to 4 genes). 
Besides, vitamin D regulates Ca2+ levels by reducing 
the expression of the voltage-dependent calcium 
channel CaV1.2.  
In this case, TPH1 is suppressed and serotonin 
formation is controlled by increasing the TPH2 level.  
Reduced expression of inflammatory cytokines 
diminishes inflammation as well (Figure 4). By 
binding to its receptor ( VDR), vitamin D also 
regulates the expression of many mitochondrial 
proteins that maintain mitochondrial respiration 
(Berridge, 2017). 
TPH1 (tryptophan hydroxylase 1) Gurbanov R, Karaçam S 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2020; 24(11) 421 
 
 
Figure 4.  Vitamin D signaling affecting TPH1 expression in depression (Simplified from 
https://www.wikipathways.org/index.php/Pathway:WP4698). 
Somatoform Disorders 
Genes in the serotonergic hypofunction and 
serotonergic pathway were thought to be associated 
with symptoms of somatoform disorders (Frodl, 
2016).  
This hypothesis has been studied using a variety of 
serotonin-related gene polymorphisms to determine 
whether the undifferentiated somatoform disorder is 
associated with specific serotonin-related gene 
pathways. 102 patients with the undifferentiated 
somatoform disorder and 133  
Healthy individuals were examined.  
It was emphasized that patients with undifferentiated 
somatoform disorder had a higher frequency of 
TPH1 (A218C) C-allele than healthy controls, but 
this difference was not significant after Bonferroni 
correction.  
These findings indicate that serotonin-related gene 
pathways are unlikely to be genetic risk factors for 
the undifferentiated somatoform disorder (Frodl, 
2016). 
Middle Insomnia 
A study found a relationship between TPH1 and 
middle insomnia. The serotonergic pathway plays an 
important role in the regulation of circadian rhythm, 
sleep, and wakefulness. Serotonergic axon release is 
high during wakefulness, decreases during non-rapid 
eye movement (NREM) sleep, and is absent during 
rapid eye movement (REM) sleep (Ursin R, 2002).  
TPH activity is most abundant in brain raphe, gut, 
and pineal gland where N-acetyltransferase converts 
serotonin to melatonin (Patel et al. 2004). Therefore, 
the polymorphism of TPH1 may affect the synthesis 
of serotonin and melatonin, so that depressed 
patients with this polymorphism are more prone to 
middle insomnia (Myung et al. 2012). 
Bipolar Disorder (BPD) 
Emotional disorders (MDD and BPD) and alcohol 
dependence are common psychiatric disorders. Nine 
studies involving 1951 cases and 2161 control 
subjects were conducted to investigate the 
relationship between TPH1 A218C polymorphism 
and BPD risk (Chen et al. 2012). Of these, 4 studies 
with 416 cases and 596 control subjects were 
conducted in Asians, whereas 5 studies with 1535 
cases and 1565 controls were conducted in 
Caucasians. A nominally significant relationship 
was observed in the homozygous model of Asian 
populations and homozygous and recessive models 
of Caucasian populations. It was found that the 
relationship between this polymorphism and the risk 
of BPD and alcohol dependence varies according to 
ethnicity, and the 218A variant homozygous 
genotype is an important risk factor for BPD and 
alcohol dependence in the Caucasians (Chen et al. 
2012). A significant relationship has been reported 
between A218C polymorphism of TPH1 intron 7 
and BPD in the French population (Lai et al. 2005). 
There was a positive relationship between BD and 
TPH1 polymorphism (rs1800532) in CC genotype, 
but no relation was found between other genotypes 
and alleles (Hormozi et al. 2019). 
Inflammation, Crohn's Disease (CD), 
and Inflammatory Bowel Disease 
(IBD) 
TPH1 catalyzes serotonin biosynthesis in EC, the 
main source of 5HT (Shajib et al. 2019). The 
secreted 5HT regulates gut functions through a 
variety of 5HT receptor (5HTR) families. In 
inflammatory bowel disease (IBD), the mucosal 
5HT signal is altered, including upregulated EC cell 
numbers and 5HT levels. The two major forms of 
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IBD are Crohn's disease (CD) and ulcerative colitis 
(UC) which are described by long-lasting and 
recurrent inflammatory lesions throughout the 
digestive tract (Shajib et al. 2019). Through TPH1, 
EC produces 5HT from dietary tryptophan (Shajib 
and Khan et al. 2015). This 5HT can then be released 
into the intestinal lumen and surrounding tissue that 
can enter the bloodstream through the dense 
capillary bed of lamina propria (Shajib et al. 2019).  
5HT has been evaluated in IBD and animal colitis 
models. TPH1-deficient mice have reduced 5HT 
content in the gut and low inflammatory cytokine 
production has been observed (Ghia et al. 2009). 
Besides, pharmacological blocking of peripheral 
5HT synthesis reduced the severity of both chemical 
and infection-related gut inflammation. In colon 
biopsy samples from CD patients, TPH1, HTR3A, 
mucosal HTR4, and HTR7 expressions were 
upregulated, whereas serotonin transporter (5HTT) 
expression was downregulated in inflammation. 
Besides, colonic TPH1 expression was found to be 
significantly higher in inflamed areas compared to 
non-inflamed areas and controls (Shajib et al. 2019). 
Other important factors such as gut microbiota, may 
also affect host 5HT production in IBD. The role of 
gut microbiota in 5-HT production, via the 
regulation of TPH1, has been shown (Yano et al. 
2015). The increase in TPH1 expression was thought 
to be associated with dysbiosis observed in IBD. In 
particular, a study showed that a 5HT increase due to 
5HTT deficiency was associated with dysbiosis. As 
a result, CD and inflammation are associated with 
increasing the mucosal 5HT signal, characterized by 
the upregulation of TPH1 expression and 
downregulation of 5HTT expression (Shajib et al. 
2019). Furthermore, high expression of IL13, a 
cytokine associated with increased 5HT production, 
is noteworthy. Increased 5HT availability due to its 
increased production and impaired clearance is 
thought to play an important role in maintaining 
intestinal inflammation and associated symptoms 
(Shajib et al. 2019). 
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